E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/21/2006 in the Prospect News Biotech Daily.

Heartscape closes $3 million series A financing

By Lisa Kerner

Erie, Pa., Feb. 21 - Heartscape Technologies, Inc. said it has raised $3 million in series A financing.

The proceeds enabled Heartscape to acquire the assets pertaining to Prime ECG technology from Meridian Medical Technologies, Inc. The funds will also be used for sales, marketing and clinical trials related to the Prime ECG system.

Radius Ventures led the round and was joined by Delta Partners and company management.

Located in Columbia, Md., Heartscape is a cardiology device company focused on the early and accurate diagnosis of heart attacks and ischemia.

Issuer:Heartscape Technologies, Inc.
Issue:Series A financing
Amount:$3 million
Investors:Radius Ventures (lead), Delta Partners, company management
Announcement date:Feb. 21

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.